These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [The activity of etoposide (VP16) in combination chemotherapy against human bladder cancer cells in vitro].
    Author: Hattori T, Satoh M, Terashima Y, Nishimura T, Akimoto M.
    Journal: Hinyokika Kiyo; 1991 Sep; 37(9):995-8. PubMed ID: 1785427.
    Abstract:
    The activity of Etoposide (VP16) in combination chemotherapy against four human transitional cell carcinoma cell lines of bladder (TCCaB) was determined by in vitro colony formation assay. Four anti-tumor agents (methotrexate: MTX, vinblastine: VBL, adriamycin: ADM, cisplatin: DDP) were used for combination chemotherapy with VP16. The ADM + VP16 combination exhibited a strong synergistic antitumor effect against the human TCCaBs compared with other combinations in this study. The combination chemotherapy of ADM + VP16 may be useful as a new chemotherapeutic regimen for advanced bladder cancer.
    [Abstract] [Full Text] [Related] [New Search]